The Journal is committed to the publication of high-quality papers in all areas of medicinal chemistry. The review should be constructive, factual, and impersonal. In order not to breach confidentiality, reviewers should never communicate directly with authors concerning their manuscript. For all categories of Articles, syntheses of all new compounds should be described in the experimental section. Appropriate literature references should be cited for all known compounds whose preparation has been previously reported.
Articles are full accounts of definitive and significant studies.
Brief Articles are definitive reports whose scope is more limited than that of Articles. However, a manuscript of limited scope should not pass as an Article if its length is greater than 16 pages. In such a case it would be appropriate to recommend that the manuscript length be reduced. Expedited Articles are in the same format as Articles and should be of extraordinary importance, novelty and timeliness to warrant expedited review and processing. The criteria for acceptance are identical to those for Letters .